STRIDES PHARMA SCIENCE LIMITED — Proxy Solicitation & Information Statement 2025

Feb 17, 2025

==> picture [118 x 39] intentionally omitted <==

February 17, 2025

BSE Limited

Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001 Scrip Code: 532531

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051 Scrip Code: STAR

Dear Sirs,

Sub: Notice of Postal Ballot

In line with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 (“Listing Regulations”), we enclose herewith Notice of Postal Ballot dated January 30, 2025, seeking approval of Shareholders of the Company for the following resolutions:

# Description of the Resolutions Type of Resolution	# Description of the Resolutions Type of Resolution	# Description of the Resolutions Type of Resolution
1. Appointment of Ms. Mukta Arora (DIN: 07225715) as an Independent Director of the Company Special
2.	Appointment of Mr. Arun Kumar (DIN: 00084845), as Non–Executive Director and Chairperson of the Board	Ordinary

Date of events relevant for Postal Ballot are as below:

==> picture [483 x 187] intentionally omitted <==

----- Start of picture text -----

Particulars Dates
1. Date of Completion of dispatch of Notice (by electronic Monday, February 17, 2025
means) to members whose names appear in the Register
of Members/ List of Beneficial Owners as received from
Depositories as on Friday, February 14, 2025
2. Date of Commencement of e-Voting Tuesday, February 18, 2025 at
09:00 hrs IST
3. Date of Ending of e-Voting (“Last Date”) Wednesday, March 19, 2025 at
17:00 hrs IST
4. Results of Postal Ballot On or before Friday, March 21, 2025
----- End of picture text -----

Postal Ballot Notice, along with the Explanatory Statement, shall be uploaded on the website of the Company at www.strides.com and on the website of KFin Technologies Limited at https://evoting.kfintech.com.

Strides Pharma Science Limited

CIN: L24230MH1990PLC057062 Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru - 560 076, India Tel: +91-80-6784 0000 Fax: +91 80 6784 0700 Regd Off: ‘ Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703, India Tel: +91-22-2789 2924/ 3199 corpcomm@strides.com; www.strides.com

==> picture [118 x 39] intentionally omitted <==

This is for your information and records.

Thanks & regards, For Strides Pharma Science Limited, Digitally signed by MANJULA MANJULA R R Date: 2025.02.17 16:29:43 +05'30'

MANJULA R

Manjula Ramamurthy Company Secretary ICSI Membership No. A30515

Encl. As above

Strides Pharma Science Limited

CIN: L24230MH1990PLC057062 Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru - 560 076, India Tel: +91-80-6784 0000 Fax: +91 80 6784 0700 Regd Off: ‘ Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703, India Tel: +91-22-2789 2924/ 3199 corpcomm@strides.com; www.strides.com

==> picture [124 x 48] intentionally omitted <==

STRIDES PHARMA SCIENCE LIMITED

CIN: L24230MH1990PLC057062

Regd. Office: Cyber one, Unit No. 902, Plot No - 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703. Tel No.: +91 22 2789 2924/ 2789 3199

Corp. Office: ‘Strides House’, Bilekahalli, Bannerghatta Road, Bengaluru – 560 076. Tel No.: +91 80 6784 0000/ 6784 0290 Website: www.strides.com; Email: investors@strides.com

NOTICE OF POSTAL BALLOT

Dear Shareholders,

NOTICE is hereby given, in accordance with Section 110 of the Companies Act, 2013 (the “ Act ”) read with Rule 20 and 22 of the Companies (Management and Administration) Rules, 2014 (“ Rules ”) including any amendment(s) thereof, Regulation 44 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (“ Listing Regulations ”), General Circular No. 14/ 2020 dated April 8, 2020, General Circular No. 17/ 2020 dated April 13, 2020, General Circular No. 22/ 2020 dated June 15, 2020, General Circular No. 33/ 2020 dated September 28, 2020, General Circular No. 39/ 2020 dated December 31, 2020, General Circular No. 10/ 2021 dated June 23, 2021, General Circular No. 20/ 2021 dated December 8, 2021, General Circular No. 3/ 2022 dated May 5, 2022, General Circular No. 11/ 2022 dated December 28, 2022, General Circular No. 09/ 2023 dated September 25, 2023 and General Circular No. 09/2024 dated September 19, 2024, issued by the Ministry of Corporate Affairs, Government of India (“ General Circulars ”) for seeking approval of the Shareholders of Strides Pharma Science Limited (the “ Company ”) for the businesses set out hereunder through Postal Ballot by remote e-voting ( “Postal Ballot/ e-voting”) :

1. Appointment of Ms. Mukta Arora (DIN: 07225715) as Independent Director of the Company for a term of five years effective February 1, 2025, not liable to retire by rotation.

2. Appointment of Mr. Arun Kumar (DIN:00084845) as Non–Executive Director and Chairperson of the Board, effective April 5, 2025, liable to retire by rotation.

MCA in terms of its General Circulars, has advised the companies to take all decisions of urgent nature requiring shareholders’ approval, other than items of ordinary business or business where any person has a right to be heard, through the mechanism of Postal Ballot/ e-Voting in accordance with the provisions of the Act and Rules made thereunder, without holding a general meeting that requires physical presence of Shareholders at a common venue.

In compliance with Regulation 44 of the Listing Regulations and pursuant to the provisions of Sections 108 and 110 of the Act read with the rules framed thereunder and the MCA Circulars, the manner of voting on the proposed resolution is restricted only to e-voting i.e., by casting votes electronically instead of submitting postal ballot form. Accordingly, the Postal Ballot Notice and instructions for e-voting are being sent only through electronic mode to those Shareholders whose email address is registered with the Company/ Depository Participant (“ DP ”).

Explanatory Statement pursuant to Section 102 of the Act setting out all material facts relating to the proposed resolution is annexed hereto for your consideration.

Scrutinizer for conducting the Postal Ballot

Board of Directors, pursuant to Rule 22(5) of the Rules, have appointed Mr. Gigi Joseph K J, Practicing Company Secretary (ICSI Membership No. F6483 and CP:5576) of M/s. Joseph & Chacko LLP, Company Secretaries, Bengaluru, as Scrutinizer for conducting the Postal Ballot/ e-Voting in accordance with the law and in a fair and transparent manner.

Page 1 of 22

==> picture [124 x 48] intentionally omitted <==

E-voting

Pursuant to Section 108 of the Act read with Rule 20 of the Rules and Regulation 44 of the Listing Regulations, the Company has engaged KFin Technologies Limited (formerly, KFin Technologies Private Limited), Registrar and Transfer Agents of the Company (“ KFintech ” or “ RTA ”), as the agency to provide e-Voting facility for its Shareholders.

Remote E-voting facility is available at the link: https://evoting.kfintech.com/ and commences from Tuesday, February 18, 2025 at 09:00 hrs IST and concludes on Wednesday, March 19, 2025 at 17:00 hrs IST .

E-Voting module shall be disabled by KFintech for voting thereafter. Shareholders desiring to exercise their votes are requested to carefully read the “ Information and Instructions relating to e-Voting ” provided in the Notes to this Notice.

Scrutinizer shall submit his Report, in writing, upon completion of scrutiny of e-Voting data provided by KFintech, in a fair and transparent manner. Result on resolution proposed to be passed through Postal Ballot/ e-Voting shall be announced on or before Friday, March 21, 2025 and shall be communicated to BSE Limited and The National Stock Exchange of India Limited (“ Stock Exchanges ”) where the equity shares of the Company are listed. Results of the Postal Ballot/ e-Voting shall also be displayed on the notice board at the Registered Office of the Company for a period of three days, on the Company’s website at www.strides.com and on the website of KFintech: https://evoting.kfintech.com/

Key details regarding the Postal Ballot/ e-Voting

#	Particulars	Details
1)	Link for remote e-Voting	https://evoting.kfintech.com/
2)	Cut-off date for eligibility for e- Voting	Friday, February 14, 2025
3)	Time period for e-voting	Commences onTuesday, February 18, 2025 at 09:00 hrs IST Ends onWednesday, March 19, 2025 at 17:00 hrs IST
4)	Last date for publishing results of the e-Voting	On or before Friday, March 21, 2025
5)	In case of any grievances or queries, contact	KFin Technologies Limited (formerly known as KFin Technologies Private Limited) Ms. Rajitha C, Vice President/ Mr. Mohan Kumar A, Senior Manager Toll Free No.: 1800 309 4001 E-mail:einward.ris@kfintech.com; evoting@kfintech.com
6)	Scrutinizer Details	Mr. Gigi Joseph K J, Practicing Company Secretary (ICSI Membership No. F6483 and CP:5576) of M/s. Joseph & Chacko LLP, Company Secretaries, Bengaluru Email:gigi@jandc.in
7)	Strides contact details	Email:investors@strides.com Tel No.: +91 80 6784 0732/ 0734

Page 2 of 22

==> picture [124 x 48] intentionally omitted <==

RESOLUTIONS FOR APPROVAL THROUGH POSTAL BALLOT

Item 1: Appointment of Ms. Mukta Arora as Independent Director of the Company

To consider and if deemed fit, to pass with or without modification(s), the following resolution as a Special Resolution :

“RESOLVED that pursuant to the provisions of Sections 149, 150, 152, 161, Schedule IV and other applicable provisions of the Companies Act, 2013 read with the Rules framed thereunder (“the Act”); applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (“the Listing Regulations”), (including any statutory modification or re-enactment(s) thereof for the time being in force); Articles of Association of the Company, recommendation of the Nomination and Remuneration Committee (“NRC”) and approval of the Board of Directors of the Company in their meeting held on January 30, 2025, Ms. Mukta Arora (DIN: 07225715) be and is hereby appointed as Independent Director of the Company for a period of Five Years from February 1, 2025 up to January 31, 2030 (both days inclusive), not be liable to retire by rotation with the following benefits:

Sitting Fees	Rs. 1 Lakh per for meeting of Board of Directors and meeting of Audit Committee. Rs. 50,000 each for each of the meetings of Nomination and Remuneration Committee, Risk Management Committee and Stakeholders Relationship Committee.
Commission/ Profit Sharing	In line with provisions of Section 197 of the Act and in accordance with the recommendations/ approvals of NRC, Board and Shareholders of the Company.

RESOLVED FURTHER that any Director or Company Secretary of the Company be and are hereby severally authorized to do all such acts, deeds, matters, things and sign and file all such papers, documents, forms and writings as may be necessary and incidental to the aforesaid resolution.”

Item 2: Appointment of Mr. Arun Kumar as Non–Executive Director and Chairperson of the Board

To consider and if deemed fit, to pass with or without modification(s), the following resolution as an Ordinary Resolution :

“RESOLVED THAT pursuant to the provisions of Section 152 and other applicable provisions of the Companies Act, 2013 read with the Rules framed thereunder (“the Act”) applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (“the Listing Regulations”), (including any statutory modification or re-enactment(s) thereof for the time being in force); Articles of Association of the Company, recommendation of the Nomination and Remuneration Committee (“NRC”) and approval of Board of Directors of the Company at their meeting held on January 30, 2025, Mr. Arun Kumar (DIN: 00084845), be and is hereby appointed as a Non-Executive Director and Chairperson of the Board of Directors of the Company, liable to retire by rotation with effect from April 5, 2025 with the following benefits:

Sitting Fees	Rs. 1 Lakh per for meeting of Board of Directors. Rs. 50,000 each for each of the meetings of Nomination and Remuneration Committee and Stakeholders Relationship Committee.
Commission/ Profit Sharing	In line with provisions of Section 197 of the Act and in accordance with the recommendations/ approval of NRC, Board and Shareholders of the Company.

Page 3 of 22

==> picture [124 x 48] intentionally omitted <==

Other Benefits	• Chairman’s Office and related expenses as permissible under Listing regulations; • Chauffer driven car for use on Company’s business; • Telephone facility at residence; & • One club Membership

RESOLVED FURTHER that any Director or Company Secretary of the Company be and are hereby severally authorized to do all such acts, deeds, matters, things and sign and file all such papers, documents, forms and writings as may be necessary and incidental to the aforesaid resolution.”

By Order of the Board For Strides Pharma Science Limited

Place: Bengaluru Date: January 30, 2025

Sd/Manjula Ramamurthy Company Secretary

Page 4 of 22

==> picture [124 x 48] intentionally omitted <==

EXPLANATORY STATEMENT (Pursuant to Section 102 of the Companies Act, 2013)

Pursuant to Section 102 of the Companies Act, 2013 (Act), Regulation 36 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) and the applicable Secretarial Standards, the following explanatory statement sets out all the material facts relating to the businesses mentioned under Item No. 1 & 2 of this Postal Ballot Notice

Item 1: Appointment of Ms. Mukta Arora as Independent Director of the Company

As a good governance measure, Board of Directors at Strides, were in the process of evaluating profiles for appointment of additional Women Independent Director, which would improve diversity and inclusion of the Strides’ Board and also strengthen the Board composition,

In the process, Members of the Nomination and Remuneration Committee (“NRC”) screened many profiles including that of Ms. Mukta Arora. Upon evaluation of Mukta’s profile, Members of the Committee were convinced that with her pharma expertise & academic background, Mukta’s induction on the Board would be of immense benefit to Strides.

Board of Directors of the Company based on the recommendation of the Nomination and Remuneration Committee in their meeting held on January 30, 2025, appointed Ms. Mukta Arora (DIN: 07225715) (“Mukta”) as Additional Director of the Company in the capacity of Independent Director for a term of Five Years with effect from February 1, 2025, subject to approval of Shareholders of the Company.

In accordance with the provisions of the Act and Listing Regulations, Company is seeking approval of Shareholders of the Company by way of Postal Ballot.

About Mukta

Mukta, aged 57 years, is a pharmaceutical Industry leader with more than three decades of experience in the pharmaceutical value chain. A gold medalist from Delhi Institute of Pharmaceutical Sciences and Research with an Executive MBA from Indian Institute of Management Bangalore.

During her career at Eli Lilly and Elanco, across India and Europe. Mukta spearheaded numerous strategic initiatives. Most notably, she successfully launched several key brands. forged several alliances, established, and scaled two Global Capability Centres (GCCs), creating substantial organizational value through innovative operational frameworks.

As the Managing Director of Elanco GCC, she orchestrated business transformation initiatives, forging crucial industry collaborations with Indian companies. Her leadership was instrumental in accelerating drug discovery and development processes, optimizing supply chains, and establishing cutting-edge technology and analytics hubs for data-driven decision-making.

Mukta's influence extends beyond corporate leadership through her active participation in prestigious industry bodies including OPPI, CII, NASSCOM, and the Vision Group of Biotechnology. A respected voice in corporate circles, she regularly speaks on critical topics such as corporate culture, diversity, equity, and inclusion (DE&I), and women's leadership.

Mukta has earned her numerous accolades, including the HR Association of India Award for DE&I Champion, the World Women Leadership Award, and the Karnataka Women Leader Award. Mukta maintains a deep commitment to corporate social responsibility, focusing on initiatives in children's health and education.

Page 5 of 22

==> picture [124 x 48] intentionally omitted <==

Other Directorships held by Mukta:

As at date, other than Strides, Mukta is not on the Board of any other Listed Company and does not hold any Committee Membership in other Companies.

Mukta has not resigned from any listed entity in the past three years.

Confirmations received from Mukta:

Company has received all statutory disclosures/ declarations from Mukta including:

• a) Consent in writing to act as director in Form DIR-2, pursuant to Rule 8 of the Companies (Appointment and Qualifications of Directors) Rules, 2014 (“the Appointment Rules”);

• b) Intimation in Form DIR 8 in terms of the Appointment Rules to the effect that he is not disqualified under sub-section (2) of Section 164 of the Act;

• c) Declaration to the effect that she meets the criteria of independence as provided in sub-section (6) of Section 149 of the Act, and Regulation 16(1)(b) of the Listing Regulations along with the confirmation that she is not aware of any circumstance or situation which exists or may be reasonably anticipated that could impair or impact her ability to discharge duties as an Independent Director of the Company;

• d) Declaration pursuant to BSE Circular No. LIST/ COMP/ 14/ 2018-19 dated June 20, 2018, and NSE Circular No. NSE/ CML/ 2018/ 24 dated June 20, 2018 that he has not been debarred from holding office of a Director by virtue of any order passed by the SEBI or any other such authority; and

• e) Confirmation about registration with the Independent Director's Data Bank maintained by Indian Institute of Corporate Affairs.

Mukta does not have any shareholding (including shareholding as a beneficial owner) in the Company and is not related to any of the Directors/ Managers/ Key Managerial Personnel of the Company.

Mukta Does not have any existing pecuniary relationship with the Company and has not received any remuneration from the Company in the past.

NRC & Board’s consideration for appointment of Mukta

As part of the evaluation process, Members of Nomination and Remuneration Committee met Mukta and evaluated her profile. It was noted that Mukta has commendable experience in pharma industry and excellent academic background.

Mukta’s profile was mapped with Strides’ Board Skill matrix and it was ascertained that her experience in areas of Operations/ Management, Leadership, Diversity & Inclusion amongst others, suits Strides’ requirement and that she would be right fit to assume the position as Independent Director.

NRC ascertained that with over three decades of experience on various capacities in pharmaceutical industry and interest in Diversity & Inclusion initiatives, Mukta’s Induction on the Board would be of Significant value addition to Strides.

NRC further confirmed that Mukta fulfils the conditions for appointment as Independent Director as per the provisions of the Act and Listing Regulations. Declarations provided by Mukta including her consent for the proposed appointment was taken on record.

Page 6 of 22

==> picture [124 x 48] intentionally omitted <==

Accordingly, NRC in their meeting held on January 29, 2025, recommended Mukta’s appointment as Independent Director to the Board of Directors of the Company effective February 1, 2025 for a period of five years, not liable to retire by rotation.

Board of Directors at their meeting held on January 30, 2025, considered the recommendation of NRC and evaluated the profile of Mukta. Board concurred with NRC’s opinion that Mukta fulfils the conditions for appointment as per provisions of the Act and Listing Regulations and she is independent of the Management.

Board believes that with Mukta’s expertise in pharma sector and her academic background, her induction to Board would be of immense benefit to Strides. Mukta’s induction would improve diversity and inclusion of Strides’ Board and also would strengthen the Board composition.

Considering the above, Board accorded its approval to appoint Mukta as Independent Director of the Company for a term of five years with effect from February 1, 2025, not liable to retire by rotation.

Further, Board also nominated Mukta as Member to the following Board Committees effective February 1, 2025:

• Audit Committee

• Nomination and Remuneration Committee

• Risk Management Committee

Remuneration proposed to be paid to Mukta:

Proposed Remuneration of Mukta is as set out in the respective resolution.

Shareholders to note that Mukta has not received any remuneration from the Company as at the date of this notice.

Recommendation to Shareholders

As elaborated above, Board believes that Mukta’s qualification and extensive experience in Pharma sector and her expertise across functions would be beneficial for the Company and recommends her appointment as Independent Director of the Company for a term of five years effective February 1, 2025.

With this appointment, Five out of Eight Directors on Strides Board are now Independent Directors, of which two are Woman Directors. Board composition demonstrates Strides’ commitment to Diversity & Inclusion.

In terms of Section 160 of the Companies Act, 2013, the Company has received notice in writing from a Member proposing the candidature of Mukta to be appointed as an Independent Director of the Company.

Copy of Mukta’s Letter of Appointment setting out the terms and conditions is available for inspection by the shareholders at the Company.

Except Mukta, none of the Directors, Key Managerial Personnel, Promoters, or their relatives are in any way concerned or interested, financially or otherwise, in the said resolution.

Board recommends passing of the resolution as set out in Item No. 1 of the Notice as a Special Resolution and requests Shareholders' approval for the same.

Page 7 of 22

==> picture [124 x 48] intentionally omitted <==

Item 2: Appointment of Mr. Arun Kumar as Non–Executive Director and Chairperson of the Board

Arun has been part of Strides’ Board since inception (June 28, 1990) and in his current term, Arun was appointed as Executive Chairperson and Managing Director of the Company effective April 7, 2022 for a term of 3 years and his present term of directorship is expiring on April 6, 2025.

Arun has served in various positions on the Board of Strides and has chaired the Board in both Executive and Non-Executive capacities in the past.

As part of the succession and re‐organization plan, Arun passed the baton to Mr. Badree Komandur to assume the position of Managing Director and Group CEO effective June 1, 2024, while continuing to be the Executive Chairperson of the Company.

In continuation to the re-organization and transition of executive responsibilities to Badree and Leadership team, it was proposed to consider Arun’s interest to assume Non-Executive position on the Board of Strides, while he continues to Chair the Board.

Board of Directors of the Company, pursuant to recommendation of Nomination & Remuneration Committee in their meeting held on January 30, 2025, unanimously approved appointment of Mr. Arun Kumar as Non – Executive Director and Chairperson of the Board, liable to retire by rotation, effective April 5, 2025.

Arun shall continue to mentor the Management & Leadership team and shall focus on building long term strategy and vision for the Company and People associated with the Company.

Pursuant to the provisions of the Act and Listing Regulations, Company is seeking approval of Shareholders of the Company by way of Postal Ballot for appointment of Arun as Non – Executive Director (Chairperson) effective April 5, 2025, liable to retire by rotation.

About Arun

Mr. Arun Kumar, aged about 64 years is the Founder and Promoter Director of the Company and is on the Board of the Company since its inception.

Arun is a commerce graduate and first-generation entrepreneur known for his intellect of building “difficult to operate” domains with high scarcity value. He founded Strides Pharma Science Limited (Strides) in 1990 and has since led the Company to the Global scale with a differentiated business model and delivering value for its stakeholders, including distribution of the most extensive dividend by a pharmaceutical company in India.

Arun was awarded the E&Y Entrepreneur of the Year for the Healthcare industry in 2000. In 2014, he also received the “India’s Best CEO Award (Mid-Sized Companies Category)” and “Best CEO in the Pharma and Healthcare Industry” from Business Today.

Other Directorships held by Arun:

1. Solara Active Pharma Sciences Limited – Non-Executive Director

2. OneSource Specialty Pharma Limited – Non- Executive Director

Arun has not resigned from any listed entity in the past three years.

Page 8 of 22

==> picture [124 x 48] intentionally omitted <==

During the FY 2024-25 till the date of this Notice, Attendance of Arun in Board/ Committee meetings is as under:

Board/ Committee	No. of Meetings held	No. of meetings attended
Board meetings	7	5
CSR Committee meetings	2	2
Stakeholders Relationship Committee meetings	4	4

Confirmations received from Arun:

Company has received all statutory disclosures/ declarations from Arun including:

• a) Consent in writing to act as director in Form DIR-2, pursuant to Rule 8 of the Companies (Appointment and Qualifications of Directors) Rules, 2014 (“the Appointment Rules”)

• b) Intimation in Form DIR 8 in terms of the Appointment Rules to the effect that she is not disqualified under sub-section (2) of Section 164 of the Act;

• c) Declaration pursuant to BSE Circular No. LIST/ COMP/ 14/ 2018-19 dated June 20, 2018, and NSE Circular No. NSE/ CML/ 2018/ 24 dated June 20, 2018 that she has not been debarred from holding office of a Director by virtue of any order passed by the SEBI or any other such authority.

Shareholding in the Company and other pecuniary relationships

• a) Arun is the founder and promoter of the Company and holds along with his relatives and Promoter group ~26.82% of the of the paid-up capital of the Company (Including the shares held Directly/ Indirectly).

• b) Mr. Aditya Arun Kumar, son of Mr. Arun Kumar is holding office as Executive Director – Business development of the Company.

• c) Details of remuneration drawn by Arun in three preceding financial years:

				In INR actuals Total remuneration 8,00,000 6,00,00,001 12,00,00,000
Financial Year	Fixed pay	Variable Pay	Sitting fee	Total remuneration
2021-22*	-	-	8,00,000	8,00,000
2022-23	1	6,00,00,000		6,00,00,001
2023-24	6,00,00,000	6,00,00,000		12,00,00,000

• During FY 2021-22 Arun was holding directorship as Non – executive Director and accordingly there was no fixed/ variable salary pay outs.

Page 9 of 22

==> picture [124 x 48] intentionally omitted <==

Recommendation of NRC & Board

NRC at their meeting held on January 29, 2025 considered the proposal for appointment of Arun as Non – Executive Chairperson. Declarations provided by Arun including his consent for the proposed appointment was taken on record.

NRC reviewed responsibilities assumed by Arun as Executive Chairperson and analysed the status of achievement for each of the responsibility assumed.

Basis the assessment, NRC believes that the Company is maintaining the momentum and is reasonably confident of achieving the outlook for FY25, with the long-term goals intact. Badree shall continue to drive the short term and long-term goals of the Company under the guidance of Arun; while Arun continues to mentor the Management & Leadership team and shall focus on building long term strategy and vision for the Company and People associated with the Company.

Considering the above assessment, NRC accorded it’s assent for Arun’s appointment as Non–Executive Chairperson and accordingly recommended Board for appointment of Arun as Non-Executive Chairperson of the Company. Proposed Remuneration of Arun as NED is as set out in the respective resolution.

Board of Directors at their meeting held on January 30, 2025 concurred with the evaluation and recommendations of NRC and accorded it’s approval for appointment of Arun as Non-Executive Chairperson of the Company effective April 5, 2025 (including proposed remuneration).

Recommendation to Shareholders

Considering the above, Board of Directors of the Company recommends appointment of Mr. Arun Kumar as Non-Executive Director and Chairperson of the Company effective April 5, 2025.

A copy of the Memorandum of Terms of Appointment with Arun is available for e-inspection by the shareholders of the Company.

Except Mr. Arun Kumar and Mr. Aditya Arun Kumar, who are part of the Promoter Group, and their relatives, none of the other Directors, Key Managerial Personnel, and their relatives are in any way concerned or interested, financially or otherwise, in the resolutions except to the extent of their shareholding as Members, if any.

Board recommends passing of the resolution as set out in Item No. 2 of the Notice as Ordinary Resolution and requests Shareholders' approval for the same.

---

Page 10 of 22

==> picture [124 x 48] intentionally omitted <==

NOTES

1. Approval of Shareholders of the Company is solicited by passing requisite resolutions through Postal Ballot/ e-Voting for businesses set out in Item 1 & 2.

Explanatory Statement pursuant to Section 102 read with Section 110 of the Act stating all material facts pertaining to the resolutions is annexed along with Postal Ballot Notice for your consideration.

Board of Directors of the Company on January 30, 2025 considered the special businesses under Item 1 & 2 as unavoidable and to be transacted through Postal Ballot/ e-Voting.

2. Postal Ballot Notice is being sent only by electronic mode to all the Shareholders of the Company , whose names appear in the Register of Members/ List of Beneficial Owners as received from National Securities Depository Limited (“NSDL”) and Central Depository Services (India) Limited (“CDSL”), (NSDL together with CDSL, the “Depositories”) and as available with the Company as at Friday, February 14, 2025 (“ Cut Off Date ”).

A copy of this Postal Ballot Notice shall also be available on the website of the Company www.strides.com, relevant section of the websites of Stock Exchanges on which the Equity Shares of the Company are listed and the website of KFin Technologies Limited (formerly, KFin Technologies Private Limited), Registrar and Share Transfer Agent of the Company (“ KFintech ” or “ RTA ”).

Voting facility only. A person who is not a Shareholder as on the Cut-off Date should treat this Notice for information purpose only.

Voting rights of a Shareholder/ beneficial owner (in case of electronic shareholding) shall be in proportion to his/ her/ its shareholding in the paid-up equity share capital of the Company as on the Cut Off Date.

3. Resolutions, if approved, by the Shareholders by means of Postal Ballot/ e-Voting is deemed to have been passed at a General Meeting of the Shareholders and the last date of the e-Voting i.e., Wednesday, March 19, 2025 shall be the date on which the Resolutions shall be deemed to have been passed, if approved by the requisite majority.

4. In compliance with Sections 108 and 110 of the Act and the Rules made thereunder and Regulation 44 of the Listing Regulations and General Circulars, Company is providing the facility to the Shareholders to exercise their votes electronically and vote on the resolutions through e- Voting facility.

Company has engaged the services of KFintech as the agency to provide e-Voting facility.

Instructions for e-Voting are provided as part of this Postal Ballot Notice which the Shareholders are requested to read carefully before casting their vote.

5. A Shareholder cannot exercise vote by sending physical Postal Ballot or by proxy on Postal Ballot.

All the Shareholders are requested to cast their votes only through remote e-Voting as per the procedure provided in Annexure 1.

6. Shareholders who have multiple folios in identical names or joint names in the same order are requested to intimate the RTA about these folios to enable consolidation of all such shareholdings into one folio.

Page 11 of 22

==> picture [124 x 48] intentionally omitted <==

7 Inspection of Documents

All documents referred in this Notice shall be available for inspection electronically.

Shareholders seeking to inspect the documents can also send an email to investors@strides.com .

8 Scrutinizer for the Postal Ballot process

Mr. Gigi Joseph K J, Practicing Company Secretary (ICSI Membership No. F6483 and CP:5576) of M/s. Joseph & Chacko LLP, Company Secretaries, Bengaluru, has been appointed as the Scrutinizer for conducting the Postal Ballot/ e-Voting in accordance with the law and in a fair and transparent manner.

Scrutinizer shall submit his Report on the resolutions proposed to be passed through Postal Ballot/ e-Voting to the Chairperson or Company Secretary of the Company after completion of the scrutiny.

The result of the voting by Postal Ballot shall be announced on or before Friday, March 21, 2025 and shall be communicated to BSE Limited and The National Stock Exchange of India Limited (“ Stock Exchanges ”) where the equity shares of the Company are listed.

The results of the Postal Ballot/ e-Voting shall also be displayed on the notice board at the Registered Office of the Company for a period of 3 (Three) days, on the Company’s website at www.strides.com and on the website of Kfintech at https://evoting.kfintech.com/.

Page 12 of 22

==> picture [124 x 48] intentionally omitted <==

General Information to Shareholders

1. Dividend Payout to Physical Folios only through Electronic Mode

SEBI vide its circular dated November 03, 2021 (subsequently amended by circulars dated December 14, 2021, March 16, 2023 and November 17, 2023) has mandated that effective April 1, 2024, dividend in respect of physical folios shall be paid only through electronic mode.

Accordingly, security holders holding securities in physical form are mandated to update their folios with their KYC documents viz., PAN, Contact Details, Mobile Number, Bank Account details etc. failing which such security holders shall not be eligible for any payment including dividend, interest or redemption in respect of such folios through electronic mode.

Upon updation of the requisite details in entirety, security holders shall be eligible to receive all the dividends declared during that period (from April 01, 2024, till date of updation) pertaining to the securities held after the said updation.

SEBI has issued FAQs in this matter which is available on their website at the following link for investor awareness:

https://www.sebi.gov.in/sebi_data/faqfiles/sep-2024/1727418250017.pdf

2. KYC updation

To prevent fraudulent transactions, Shareholders are advised to exercise due diligence and notify the Company of any change in address, as soon as possible. Further, in case of demise of a Shareholder, their legal heirs are requested to notify the Company, at their earliest convenience.

Shareholders are also advised to not leave their demat account(s) dormant for long. Periodic statement of holdings should be obtained from the concerned Depository Participant(s) and holdings should be verified from time to time.

Non-Resident Indian Shareholders are requested to inform RTA/ respective Depository participants, immediately of any:

• a) Change in their residential status on return to India for permanent settlement; and

• b) Particulars of their bank account maintained in India with complete name, branch, account type, account number and address of the bank with pin code, if not furnished earlier.

Procecure for KYC Updation

Shareholders holding shares in electronic form and who have not updated their PAN and KYC are requested to submit the details to their Depository Participant(s).

Shareholders holding shares in physical mode and who have not updated their details are requested to furnish the documents/ details, as per the table below, to KFintech at their earliest convenience:

Page 13 of 22

==> picture [124 x 48] intentionally omitted <==

Type of Holder	Particulars	Form
Physical	Form for availing investor services to register PAN, email address, bank details and other KYC details or changes/ update thereof for securities held in physical mode	Form ISR - 1
	Update of signature of securities holder	Form ISR - 2
	Declaration to opt out Nomination	Form ISR-3
	Form for requesting issue of Duplicate Certificate for shares held in physical form	Form ISR-4
	Request for transmission of Securities by Nominee or Legal Heir	Form ISR-5
	Nomination form	Form: SH-13
	Cancellation of nomination by the holder(s) (along with ISR-3)/ Change of Nominee	Form: SH-14
Demat	Shareholders to contact their Depository Participants and register their email address and bank account details in their demat account, as per the process advised by the Depository Participants.

The aforesaid forms can be downloaded from the website of the Company and RTA at: https://www.strides.com/Shareholders_service_request.html; & https://ris.kfintech.com/clientservices/isc/isrforms.aspx

Shareholders are requested to forward the duly filled in and executed documents along with the related proofs as mentioned in the respective forms to the following address:

KFin Technologies Limited

(Formerly known as KFin Technologies Private Limited), Unit: Strides Pharma Science Limited

Selenium Tower B, Plot 31-32, Gachibowli, Financial District, Nanakramguda, Hyderabad – 500 032 Toll Free No.: 1800 309 4001 E-mail: einward.ris@kfintech.com

The above mentioned ISR Form(s) and the supporting documents can be provided by any one of the following modes:

a) Through ‘In Person Verification’ (IPV): the authorized person of the RTA shall verify the original documents furnished by the investor and retain copy(ies) with IPV stamping with date and initials;

b) Through hard copies which are self-attested, which can be shared on the address below;

Page 14 of 22

==> picture [124 x 48] intentionally omitted <==

Name	KFIN Technologies Limited Unit: Strides Pharma Science Limited
Address	Selenium Building, Tower-B, Plot No 31 & 32, Financial District, Nanakramguda, Serilingampally, Hyderabad, Rangareddy, TelanganaIndia-500 032.

c) Through electronic mode with e-sign by following the link: https://ris.kfintech.com/clientservices/isc/isrforms.aspx

Detailed FAQ can be found on the link: https://ris.kfintech.com/faq.html

For more information on updating the email and Mobile details for securities held in electronic mode , please reach out to the respective DP(s), where the DEMAT A/c is being held.

3. Withdrawal of the requirement of Freezing of Folios

SEBI vide its Circular SEBI/ HO/ MIRSD/ POD-1/ P/ CIR/2023/181 dated November 17, 2023 has done away with the requirement of freezing of folios and referring frozen folios to the administering authority under the Benami Transactions (Prohibitions) Act, 1988 and/ or Prevention of Money Laundering Act, 2002.

4. Issue/ Transfer of Shares in demat mode only

In terms of the SEBI Listing Regulations, securities of listed companies can only be transferred in dematerialized form with effect from April 1, 2019.

Further, as an ongoing measure to enhance ease of dealing in securities by investors, SEBI vide its Circular dated January 25, 2022, has mandated listed companies to issue securities in demat form only while processing service requests such as transfer, transmission, issue of duplicate share certificates, renewal/ exchange of share certificates, consolidation of folios etc.

In terms of the Circular,

1. Claimant/ Securities Holder shall submit their request in Form ISR-4 (hosted on website of Company and RTA) along with requisite documents and details;

2. RTA shall verify the request and documents submitted and thereafter issue a Letter of Confirmation (LoC) in lieu of physical securities certificates to the Claimant/ Securities Holder within 30 days of receipt of such request;

3. LoC shall be valid for a period of 120 days from the date of its issuance;

4. Claimant/ Securities Holder to make a request to the Depository Participant for dematerializing the said securities;

5. In case the Claimant/ Securities Holder fails to submit the demat request within the prescribed period, such shares shall be credited to the Suspense Escrow Demat Account of the Company;

Claimant/ Securities Holder to reinitiate the process for claiming shares from the Suspense Escrow Demat Account of the Company.

Page 15 of 22

==> picture [124 x 48] intentionally omitted <==

5. KPRISM – Unified platform for investment monitoring

KPRISM is a unified platform launched by Kfintech for your Equity Investment Monitoring with multiple Self-Help Features.

You may access KPRISM on their website link provided below or through the mobile app named ‘KPRISM’.

https://kprism.kfintech.com/

Shareholders can download this android mobile application from play store and view their portfolios serviced by KFintech.

In addition, Shareholders may also visit the Investor Support Center (ISC) webpage at https://ris.kfintech.com/clientservices/isc/default.aspx and access various services such as post or track a query, upload tax exemptions forms, view the demat/ remat request, check the dividend status, download the required ISR forms and check KYC status for physical folios, amongst others.

---

Page 16 of 22

==> picture [124 x 48] intentionally omitted <==

Annexure 1

GENERAL INSTRUCTIONS TO CAST VOTES THROUGH REMOTE E-VOTING

I PROCEDURE FOR REMOTE E-VOTING

• 1) In compliance with the provisions of Section 108 of the Act, read with Rule 20 and 22 of the Companies (Management and Administration) Rules, 2014, as amended from time to time, Regulation 44 of the SEBI Listing Regulations and in terms of SEBI Circular No. SEBI/ HO/ CFD/ CMD/ CIR/ P/ 2020/ 242 dated December 9, 2020, SEBI Master Circular No. SEBI/ HO/ CFD/ PoD2/ CIR/ P/ 2023/ 120 dated July 11, 2023 and SEBI Circular No. SEBI/ HO/ CFD/ CFD-PoD-2/ P/ CIR/ 2023/ 167 dated October 7, 2023, in relation to e-voting facility provided by Listed Entities, Shareholders are provided with the facility to cast their vote electronically, through the e-voting services provided by KFin Technologies Limited (Formerly, KFin Technologies Private Limited) (KFintech), on the resolutions set forth in this Notice.

• 2) Voting rights of the Shareholders shall be in proportion to their shares in the paid-up equity share capital of the Company as on the Cut-off date i.e., Friday, February 14, 2025 .

A person who is not a shareholder as on the Cut-off date should treat this Notice for information purposes only.

Once the vote on a Resolution is cast by the shareholder, the shareholder shall not be allowed to change it subsequently.

The e-voting facility will be available during the following period:

• Commencement of e-Voting: 09:00 hrs IST on Tuesday, February 18, 2025.

• End of e-Voting: 17:00 hrs IST on Wednesday, March 19, 2025.

Remote e-Voting will not be allowed beyond the aforesaid date and time and the remote-eVoting module shall be forthwith disabled by KFintech upon expiry of the aforesaid period.

The process and manner of e-Voting shall be as under:

Step 1: Access to Depositories e-voting system in case of individual Shareholders holding shares in demat mode.

Step 2: Access to KFintech e-voting system in case of Shareholders holding shares in physical form and non-individual Shareholders in demat mode.

2.1) Details on Step 1 are mentioned below:

Login method for remote e-voting for Individual Shareholders holding securities in demat mode.

NSDL Individual Shareholders holding securities in demat mode with NSDL

• I. Instructions for existing Internet-based Demat Account Statement (“IDeAS”) facility Users:

a) Visit the e-services website of NSDL https://eservices.nsdl.com.

Page 17 of 22

==> picture [124 x 48] intentionally omitted <==

• b) On the e-services home page click on the “Beneficial Owner” icon under “Login” under ‘IDeAS’ section.

• c) A new page will open. Enter the existing user id and password for accessing IDeAS.

• d) After successful authentication, Shareholders will be able to see e-voting services under ‘Value Added Services’.

• e) Please click on “Access to e-voting” under e-voting services, after which the e- voting page will be displayed.

• f) Click on company name, i.e., ‘Strides Pharma Science Limited’, or e-voting service provider, i.e., KFintech.

• g) Shareholders will be re-directed to KFintech’s website for casting their vote during the remote e-voting period.

II. Instructions for those Shareholders who are not registered under IDeAS:

• a) Visit https://eservices.nsdl.com for registering.

• b) Select “Register Online for IDeAS Portal” or click at https://eservices.nsdl.com/SecureWeb/IdeasDirectReg.jsp

• c) Visit the e-voting website of NSDL https://www.evoting.nsdl.com/.

• d) Once the home page of e-voting system is launched, click on the icon “Login” which is available under ‘Shareholder / Member’ section. A new screen will open.

• e) Shareholders will have to enter their User ID (i.e., the sixteen digits demat account number held with NSDL), password / OTP and a Verification Code as shown on the screen.

• f) After successful authentication, Shareholders will be redirected to NSDL Depository site wherein they can see e-voting page.

• g) Click on company name, i.e., Strides Pharma Science Limited or e-voting service provider name, i.e., KFintech, after which the member will be redirected to e- voting service provider website for casting their vote during the remote e-voting period.

III. Users may alternatively vote by directly accessing the e-Voting website of NSDL

• a) Open https://www.evoting.nsdl.com/ either on a Personal Computer or on a mobile.

• b) Click on the icon “Login” which is available under ‘Shareholder/ Member’ section.

• c) A new screen will open. You will have to enter your User ID (i.e. your sixteen digit Demat account number held with NSDL), Password/ OTP and a Verification Code as shown on the screen.

• d) Post successful authentication, you will be redirected to NSDL Depository site wherein you can see e-Voting page.

Page 18 of 22

==> picture [124 x 48] intentionally omitted <==

• e) Click on company name, i.e., ‘ Strides Pharma Science Limited ’ or e-voting service provider name, i.e., KFintech, after which the member will be redirected to e-voting service provider website for casting their vote during the remote e-voting period.

NSDL Mobile App

Shareholders can also download the NSDL Mobile App “NSDL Speede” facility by scanning the QR code for seamless voting experience.

==> picture [130 x 85] intentionally omitted <==

CDSL Individual Shareholders holding securities in demat mode with CDSL

• a) Users who have opted for CDSL Easi/ Easiest facility, can login through their existing user id and password. Option will be made available to reach e-Voting page without any further authentication.

• b) The users to login to Easi/ Easiest are requested to visit CDSL website www.cdslindia.com and click on login icon & New System Myeasi Tab.

• c) After successful login the Easi/ Easiest user will be able to see the e-Voting option for eligible companies where the evoting is in progress as per the information provided by company.

• d) On clicking the evoting option, the user will be able to see e-Voting page of the e- Voting service provider for casting your vote during the remote e-Voting period or joining virtual meeting & voting during the meeting, as applicable.

• e) Additionally, there is also links provided to access the system of all e-Voting Service Providers, so that the user can visit the e-Voting service providers’ website directly.

• f) If the user is not registered for Easi/ Easiest , option to register is available at CDSL website www.cdslindia.com and click on login & New System Myeasi Tab and then click on registration option.

• g) Alternatively, the user can directly access e-Voting page by providing Demat Account Number and PAN No. from a e-Voting link available on www.cdslindia.com home page.

• h) The system will authenticate the user by sending OTP on registered Mobile & Email as recorded in the Demat Account.

• i) After successful authentication, user will be able to see the e-Voting option where the e-voting is in progress and also able to directly access the system of all e-Voting Service Providers.

Page 19 of 22

==> picture [124 x 48] intentionally omitted <==

Individual Shareholders login through their demat accounts/ Website of Depository Participant

• a) Shareholders can also login using the login credentials of their demat account through their DP registered with the Depositories for e-voting facility.

• b) Once logged-in, Shareholders will be able to view e-voting option.

• c) Upon clicking on e-voting option, Shareholders will be redirected to the NSDL / CDSL website after successful authentication, wherein they will be able to view the e-voting feature.

• d) Click on options available against ‘ Strides Pharma Science Limited’ or KFintech.

• e) Shareholders will be redirected to e-voting website of KFintech for casting their vote during the remote e-voting period without any further authentication.

Important note:

Shareholders who are unable to retrieve User ID / Password are advised to use Forgot user ID and Forgot Password option available at respective websites.

Helpdesk for individual Shareholders holding securities in demat mode for any technical issues related to login through NSDL/ CDSL:

Login type	Helpdesk details
Securities held with NSDL	Please contact NSDL helpdesk by sending a request at evoting@nsdl.co.in or Contact at no.: 022-48867000
Securities held with CDSL	Shareholders facing any technical issue in login can contact CDSL helpdesk by sending a request at helpdesk.evoting@cdslindia.comor Contact at Toll free no.: 1800 22 55 33

2.2) Details on Step 2 are mentioned below:

Login method for Shareholders holding shares in physical form and non-individual Shareholders in demat mode

(A) Instructions for Shareholders whose email IDs are registered with the Company/ Depository Participant(s)

Shareholders whose email IDs are registered with the Company / Depository Participant(s) will receive an email from KFintech which will include details of E-voting Event Number (EVEN), USER ID and password.

They will have to follow the following process:

• a) Launch internet browser by typing the URL: https://evoting.kfintech.com/

Page 20 of 22

==> picture [124 x 48] intentionally omitted <==

• b) Enter the login credentials (i.e., User ID and password). In case of physical folio, User ID will be EVEN (E-Voting Event Number) followed by folio number.

• c) In case of Demat account, User ID will be your DP ID and Client ID.

• d) However, if a member is registered with KFintech for e-voting, they can use their existing User ID and password for casting the vote.

• e) After entering these details appropriately, click on “LOGIN”.

• f) Shareholders will now reach password change Menu wherein they are required to mandatorily change the password.

• g) The new password shall comprise of minimum 8 characters with at least one upper case (A-Z), one lower case (a-z), one numeric value (0-9) and a special character (@,#,$, etc.,).

• h) The system will prompt the member to change their password and update their contact details viz. mobile number, email ID etc.

• i) On first login, Shareholders may also enter a secret question and answer of their choice to retrieve their password in case they forget it. It is strongly recommended that Shareholders do not share their password with any other person and that they take utmost care to keep their password confidential.

• j) Shareholders would need to login again with the new credentials.

• k) On successful login, the system will prompt the member to select the “EVEN”, viz., ‘ Strides Pharma Science Limited – Postal Ballot’ , and click on “Submit”.

• l) On the voting page, enter the number of shares (which represents the number of votes) as on the Cut-off Date under “FOR/ AGAINST” or alternatively, a member may partially enter any number in “FOR” and partially “AGAINST” but the total number in “FOR/ AGAINST” taken together shall not exceed the total shareholding as mentioned herein above.

• m) A member may also choose the option ABSTAIN.

• n) If a member does not indicate either “FOR” or “AGAINST” it will be treated as “ABSTAIN” and the shares held will not be counted under either head.

• o) Shareholders holding multiple folios/ demat accounts shall choose the voting process separately for each folio / demat account.

• p) Shareholders may then cast their vote by selecting an appropriate option and click on “Submit”.

• q) A confirmation box will be displayed. Click “OK” to confirm else “CANCEL” to modify.

• r) Once Shareholders have voted on the resolution(s), they will not be allowed to modify their vote. During the voting period, Shareholders can login any number of times till they have voted on the Resolution.

Page 21 of 22

==> picture [124 x 48] intentionally omitted <==

• s) Corporate/ Institutional members (corporate / FIs / FIIs / trust / mutual funds / banks, etc.) are required to send scanned copy (pdf format) of the relevant board resolution to the Scrutinizer through e-mail to gigi@jandc.in with a copy to evoting@kfintech.com.

• t) The file scanned image/ pdf file of the board resolution should be in the naming format “Corporate Name”.

(B) Instructions for Shareholders whose email IDs are not registered with the Company / Depository Participant(s), and consequently the Postal Ballot Notice and e-voting instructions cannot be serviced:

Shareholders are requested to follow the process as guided to capture the email address and mobile number for receiving the soft copy of the Postal Ballot Notice and e-voting instructions along with the User ID and Password. In case of any queries, Shareholders may write to einward.ris@kfintech.com.

(C) Method for obtaining user id and password for Shareholders who have forgotten the User ID and password

Shareholders who have forgotten the user id and password, may obtain/ retrieve the same in the manner mentioned below:

If the mobile number of the member is registered against Folio No. / DP ID Client ID, the member may send SMS: MYEPWDE-voting Event Number (EVEN) + Folio No. or DP ID Client ID to +91 9212993399

Example for NSDL: MYEPWDIN12345612345678 Example for CDSL: MYEPWD1402345612345678

Example for Physical: MYEPWD XXXX1234567890

If email ID of the member is registered against Folio No. / DP ID Client ID, then on the home page of https://evoting.kfintech.com, the member may click ‘Forgot password’ and enter Folio No. or DP ID Client ID and PAN to generate a password.

Shareholders may send an email request to einward.ris@kfintech.com.

If the member is already registered with the KFintech e-voting platform then such member can use his/ her existing User ID and password for casting the vote through remote e-voting.

Shareholders may call KFintech toll free number 1-800-309-4001 for any clarifications/ assistance that may be required.

• D. In case of any queries, you may refer the Frequently Asked Questions (FAQs) for shareholders and e-voting User Manual for shareholders available at the download section of https://evoting.kfintech.com/public/Faq.aspx

---

Page 22 of 22